Results 191 to 200 of about 280,456 (250)

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients. [PDF]

J Cardiovasc Dev Dis, 2018
Julius U.
europepmc   +1 more source

Clinical outcomes, perfusion and vascular function in patients with refractory angina and raised lipoprotein (a), treated with lipoprotein apheresis

, 2016
Tina Khan
openalex   +2 more sources

Low-density-lipoprotein (LDL) apheresis treatment for severe arteriosclerosis obliterans (ASO) in patients on chronic hemodialysis.

, 2002
Kunihiko Yoshiya, Yutaka Kondo, Yukihito Hasunuma, Nobutoshi Oka, Hiroshi Ohmae, Shoji Hara, Isao Hara, Sadao Kamidono   +7 more
openalex   +2 more sources

Lipoprotein Apheresis - Own Experience

Annals of Medical and Health Sciences Research, 2020
openaire  

The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on. [PDF]

Clin Res Cardiol Suppl, 2017
Schettler VJJ, Neumann CL, Peter C, Zimmermann T, Julius U, Roeseler E, Heigl F, Grützmacher P, Blume H, Vogt A, Scientific Board of GLAR for the German Apheresis Working Group.   +10 more
europepmc   +1 more source

Low-density lipoprotein apheresis: an evidence-based analysis.

, 2007
Medical Advisory Secretariat
openalex   +1 more source

Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis

, 2016
Yuka Sugawara, Kenjiro Honda, Daisuke Katagiri, Motonobu Nakamura, Takahisa Kawakami, Ryo Nasu, Akimasa Hayashi, Yukako Shintani‐Domoto, Akihiro Tojo, Eisei Noiri, Mineo Kurokawa, Masashi Fukayama, Masaomi Nangaku   +12 more
openalex   +2 more sources

The Pathological Role of LDL in Membranous Nephropathy and Diabetic Nephropathy and the Protective Efficacy of LDL Apheresis: A Narrative Review. [PDF]

Toxins (Basel)
Kodama G, Taguchi K, Wada Y, Nakano K, Shibata R, Fukami K.   +5 more
europepmc   +1 more source